Thermo Fisher Scientific seeks to buy pharmaceutical testing company for $17.4B

Thermo Fisher Scientific said April 15 it plans to acquire PPD, a North Carolina-based pharmaceutical testing company.

Thermo Fisher's board of directors have approved a definitive agreement to acquire PPD for $17.4 billion plus an assumption of about $3.5 billion of net debt, according to a news release. 

PPD is a company that tests experimental prescription drugs and provides lab services. Thermo Fisher said it generated a revenue of $4.7 billion in 2020. It's set to become a part of Thermo's laboratory products and services segment. 

The transaction is expected to be completed by the end of 2021. 

Read the full news release here

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.